Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

The American Journal of Clinical Nutrition, 2026

Height variation independent of known genetic variants and health in later life: a cohort study

Zhang Y., Li Y., Xue X. et al.

JACC: Basic to Translational Science, 2026

Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease

Tan E., Sim M., Choi H. et al.

Metabolism, 2026

Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes

Deng K., Hameete A., Schrauwen P. et al.

Clinical Gastroenterology and Hepatology, 2026

Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank

Kim H., Rezaee-Zavareh M., Wang Y. et al.

npj Science of Food, 2026

BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention

Zheng Y., Li Y., Gao Y. et al.

BMC Neurology, 2026

A preliminary analysis of the inflammatory protein landscape in the CSF of mid- to late-stage Parkinson’s disease: associations with motor severity and subtypes

Guo Y., Liu W., Bu W. et al.

Comprehensive Physiology, 2026

Insight Into the Biological Link Between Novel Adiposity Indices and Incident Heart Failure

Yang Y., Li J., Xiao X. et al.

Frontiers in Medicine, 2026

Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics

Zhu L., Chen W., Shen N. et al.

Journal of Advanced Research, 2026

Integrating clinical, proteomics, and polygenic scores to improve cardiovascular risk prediction: a prospective cohort study

Ding Y., Hong G., Wang Z. et al.

Gut Microbes, 2026

Multi-omics analysis of saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression

Vaaben T., Lützhøft D., Hedin K. et al.

Frontiers in Immunology, 2026

TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis

Evangelista J., Nisperuza Vidal A., Xu D. et al.

Aging Cell, 2026

Bidirectional Relationship and Shared Mechanisms Between Sarcopenia and Osteoporosis: An Observational Study Integrating Genomic, Proteomic, and Metabolomic Data

Xu S., Wen S., Zong X. et al.

The Journal of Nutrition, 2026

Oat-Rich Low-Gluten Diet Modulates Plasma Short-Chain Fatty Acids without Significant Changes in Fecal Microbiome or Inflammatory Markers—A Randomized Clinical Trial in People with Cardiometabolic Risk

Mannila E., Gómez-Gallego C., Muluh G. et al.

Journal of Clinical Investigation, 2026

Rheumatoid factor production is genetically and molecularly distinct from rheumatoid arthritis

Hocaoglu M., Sawalha A.

Inflammation Research, 2026

Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury

Van Nynatten L., Tweddell D., Daley M. et al.

International Journal of Molecular Sciences, 2026

APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis

Dźwigała M., Sys D., Życka-Krzesińska J. et al.

Journal of Inflammation Research, 2026

Paired Tear Fluid – Plasma Inflammatory Profiling Identifies Compartment-Specific Biomarkers for Diabetic Retinopathy and Diabetic Macular Edema

Yu T., Li S., Cheng F. et al.

Psychotherapy and Psychosomatics, 2026

Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways

Wei W., Cheng B., He D. et al.

Journal of Cardiovascular Translational Research, 2026

The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling

Los J., Mensink F., Bulut ?. et al.

Scientific Reports, 2026

Plasma COL3A1 propeptide as a promising prognostic marker in oral squamous cell carcinoma

Magan M., Gu X., Sgaramella N. et al.

4520 publications